Ciro Isidoro is a Full Professor of General Pathology at the Department of Health Sciences, University of Piemonte Orientale (Novara, Italy). He holds a Doctor of Science degree in Biological Sciences (Magna cum Laude) and a Doctor of Medicine and Surgery degree (Magna cum Laude). The Faculty of Medicine and Pharmacy at the Université de la Franche-Comté in Besançon, France, awarded him Professor Honoris Causa. He is an Adjunct Professor at the Siriraj Faculty of Medicine, Mahidol University in Bangkok, Thailand, and at the Department of Cell Biology, Oklahoma University Health Science Center in Oklahoma City, USA.

Professor Isidoro serves as Editor-in-Chief of the Journal of Cancer and Metastasis Treatment and of the Journal of Cell Metabolism in Medicine, and as Associate Editor for Autophagy, Journal of Translational Medicine, Molecular Carcinogenesis, Cancers, Frontiers in Oncology, Cells, Biomedicines, and the International Journal of Molecular Sciences, among others. He is a globally recognized expert in autophagy and lysosome biogenesis. His research focuses on the role of autophagy-lysosomal degradation in cancer and neurodegenerative diseases, as well as the epigenetic mechanisms of anti-tumor nutraceuticals.

Professor Isidoro has authored more than 250 peer-reviewed articles, with over 25,000 citations and an H-index of 58. He was listed as a TOP 2% scientist in the world in 2023 and as a top Italian scientist.